Launch of Aptadir Therapeutics With a Novel Class of RNA Inhibitors
A novel approach for intractable cancers and genetic conditions Science originates from 3 top international institutions – the Beth Israel Deaconess Medical Center of the Harvard Medical School, the Italian Research National Council (CNR) and the C...